Advanced Search
Contact | Corporate | Help

Daily news email for August 30, 2010 | Click here for updated news

SourceSolution News
New reporting features added to the Supplier Relationship Management system. Sign up here for our daily webinar to learn more.

Search over 86,000 clinical trials by phase of development and indication at www.sourcesolution.com

PlanIt client portal software lets you exchange and track documents, manage budgets and assign tasks. 3 day implementation!

 BioSpace
Vitamin A Hikes HIV Loads in Breast Milk, University of Michigan Study

CEO: Johnson & Johnson Let Down Public, Must Work to Build Trust

Omega-3 Margarines Fail to Help in Heart Study, Wageningen University Study

U.S. FDA Gets Tougher With Certain Drug Trials; Limiting Use of "Non-inferiority" Clinical Trials

The FDA Is Cracking Down On Non-Inferiority Trials

BioSpace - Breaking News
BioDelivery Sciences International Release: BEMA Buprenorphine Phase 2 Study Results Selected for Presentation at Pain Week 2010

Advanced Life Sciences' Journal Publication Highlights Powerful Chemistry Platform

Forest Laboratories, Inc. and Gedeon Richter Ltd. Announce Results from a Phase II Study of Cariprazine for the Treatment of Bipolar Depression

Forest Laboratories, Inc., Gedeon Richter Ltd. May Do Additional Phase II Cariprazine Trial; Drug Misses Overall Goal

MEDA Acquires Alaven Pharmaceutical LLC, A US Specialty Pharma Company For 350 MUSD

Biotech News - Business Wire
Advanced Cell Technology's Robust Cell Reprogramming/Transdifferentiation Platform Well Positioned To Capitalize on Emerging Trends in Regenerative Medicine

Biomagnetics Announces LOI to Acquire Lanzhou New Sunshine Plastics Industry LTD Fourth Chinese Asset Targeted at $1.50 BMGP Share Price

EHSI: MedAnywhere Breakthrough Medical iPhone App Module Proceeds to Final Testing Phase

Lineagen, Inc. Closes $5 Million to Complete $10.8 Million Series A Round

CryoPort to Present at the Rodman & Renshaw Global Investment Conference on September 13

 Biotech News - PR Newswire
Rx Communications Group to Ring NASDAQ Closing Bell

Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology

Alere Earns NCQA Patient and Practitioner Oriented Full Accreditation for Disease Management Program

BMP Sunstone's 'Hao Wawa' (Good Baby) Brand Ranked First Among China's Top Three Pediatric Medicine Brands

Yongye International Announces Opening of New Production Facility

 Biotechnology - Moreover
Sanofi Goes Public with Genzyme Offer

Biotechnology Can Change Country's Agriculture

Novartis provides forum for future research and business leaders to engage in scientific innovation

Lab Washer-Disinfectors Meet 21st Centur...

Stock futures flat after M&A flurry as investors cautious
Burrill Report
Roche Dominates the Deal Flow

Abuse Concerns Lead FDA Committee to Reject Expanded Use of Jazz Pharmaceuticals Drug

Costs of Scientific Misconduct

Legislators Weigh Goals of Personalized Medicine Bill

Retrovirus Linked to Chronic Fatigue Syndrome

 CenterWatch - Clinical Trials
Parexel introduces temperature control process

Competitors MDCI and CDSS form cross-continental CRO partnership

Synexus sees clinical trials rise 25% in Hungary

Merck partners with Alectos to develop new type of Alzheimer's treatment

Medco Health Solutions to acquire United BioSource in $730 million all-cash deal

 Clinical Trials - Business Wire
Aptus Endosystems Completes $15 Million Series AA Financing

Medical Action Industries Inc. Completes Acquisition of AVID Medical, Inc.

Pico-Tesla Expands Operations to Midwest Region

AUXILIO Provides Business Update and Outlook

ArtVentive Medical Group, Inc. and Medical Murray Inc. Sign Agreement
Clinical Trials - PR Newswire
Pulmonary Fibrosis Foundation Contributes $200,000 in New Pulmonary Fibrosis Research, Totaling $400,000 in Grants

Study Points to Key Genetic Driver of Severe Allergic Asthma

Alzheimer's Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology

Shire Announces European Approval of VPRIV(R) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease

BrainScope(TM) Announces Findings of Traumatic Brain Injury Study in the Emergency Department

 Contract Pharma
Meda Acquires Alaven

Executive Moves: PharmaNet

Xcelience, IriSys in Alliance

Shire Gaucher Drug Gains EU Approval

Ricerca Completes cGMP API Purification

FDA Drugs- What's New
September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement

FDA Drug Safety Communication: Ongoing Safety Review of Stalevo and possible increased cardiovascular risk

FDA Drug Safety Communication: Aseptic meningitis associated with use of Lamictal (lamotrigine)

FDA Drug Safety Communication: Serious medication errors from intravenous administration of nimodipine oral capsules

FDA Drug Safety Communication: Ongoing safety review of Evamist (estradiol transdermal spray) and unintended exposure of children and pets to topical estrogen
FDA News - Business Wire
Biomoda to Participate in Rodman & Renshaw Annual Healthcare Conference in New York City

Eisai Announces Extension of FDA Review of Drug Application for Investigational Agent Eribulin Mesylate

Nanotherapeutics Submits Investigational New Drug Application to FDA for Clinical Testing of Oral Drug to Treat Radiation Exposure

Xcelience and IriSys Business Alliance Agreement Strengthens Regional Access to CMC/Regulatory Expertise

Genzyme Confirms Receipt of Unsolicited Proposal

 FDA Press Releases
FDA Warns Consumers to Avoid TimeOut Capsules

FDA releases guidance on federal menu labeling requirements

FDA Warns of Possible Dangers from Portable Foot-Tanning Device

Study: Presence of murine leukemia virus found in CFS Patients, others

Urgent Nationwide Frozen Mamey Fruit Products Recall

 FDA Vaccines, Blood and Biologics - What's New
August 24, 2010 Approval Letter - Fluvirin

URGENT - Voluntary Market Withdrawal of Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation

July 19, 2010 Approval Letter - Fluarix

Recall of Panoscreen lll

AFLURIA
FierceBiotech
FDA wants more data on AZ's motavizumab

ImmunoSolv merges to avoid 'one trick pony' syndrome

Genzyme rejects Sanofi's $18.5B offer

Eisai heart drug may lower heart risks

Otonomy lands $38.5M for ear disorder work

 FierceBiotech IT
Better modeling to reduce animal testing

Risk approach comes to site monitoring

Researchers pit local vs. cloud clusters in compute-intensive race

EU inspectors tap CDISC in GCP guidance

Grass-roots effort drives cloud business case

 FierceBiotech Research
Mouse virus linked to chronic fatigue syndrome

Mouse virus found in chronic fatigue cases

Judge's ruling throws ESC research work into disarray

Tougher disclosure rules spur flak from biomedical researchers

AVI approach saves monkeys with Ebola
FiercePharma
Genzyme snubs Sanofi, but investors might not

Pfizer settles Prempro case, avoiding retrial

J&J CEO likely to weather current woes

European guidelines could spur Multaq use

Will gene-testing be a blood-thinner battleground

 FiercePharma Manufacturing
FDA moves a step closer to executive prosecutions

Lilly, Pfizer announce manufacturing cuts

Robotic IV compounding comes to UMass

Hyaluron contamination response earns FDA warning

Texas kicks in for vegan vaccine funding

 FierceVaccines
Bill Gates on vaccines: "Our investment is mind-blowing"

Will FDA reconsider hen vaccination program

Antigenics shares gain on GSK's ambitious PhIII vax program

Feds earmark $2B for new, faster vaccine tech

CDC: More teens getting their recommended shots
Health News - BizJournals.com
Vivante acquired by Swiss pharma company

Emdeon aims to ease pharmacies' billing headaches with vaccines, non-drug sales

Troubled Deaconess Hospital cutting jobs, services

Genzyme rejects Sanofi bid

Construction begins on LEED-rated Austin clinic

 Health News - CNBC
King Pharma names Bailey chief commercial officer

Covidien completes sale of 2 businesses

BioMarin's Pompe disease drug gets orphan status

Stocks dip as investors enter week cautiously

3M to acquire Cogent for about $943 million

 Health News - Fox Business
Genzyme Rejects Sanofi $18.5 Billion Offer As 'Unrealistic'

Genzyme Rejects Sanofi-Aventis $18.5 Billion Offer As 'Unrealistic'

Forest-Gedeon Richter Drug Misses Overall Goal

Russia's Pharmsynthez Plans IPO To Raise RUB500 Million

Sanofi-Aventis: Relapsing-MS Drug Meets Endpoint
Inside Industry - Gen
Genzyme Dismisses Sanofi-Aventis' Public $18.5B Takeover Bid

Going live to the beating heart

Otonomy Secures $38.5M to Support Pipeline of Therapies for Ear Disorders

Lonza Acquires Vivante to Expand into Viral-Based GMP Manufacturing

 Marketwire - Pharma and Biotech
Taglich Brothers Initiates Coverage on BioCurex, Inc.

Pharmacogenomics Offers New Opportunities in the Molecular Diagnostics Field

Novora BioMedical Corporation(TM) Announces Launch of 100% Natural Mouth Rinse

BioServe Introduces the BioServe Network

Research Reports on Mylan and Watson Pharmaceuticals - Generic Drug Makers Striving Successfully

 MassBio News
Massachusetts maintains national strength in biotech despite downturn

MassBio Statement on Stem Cell Decision

Sixteen MassBio Member Companies Selected to Present at BioPharm America 2010 and the MassBio Investors Forum

Check out the MassBio Innovation Exchange!

Nuclea Biotechnologies opens new Genomic Center in Pittsfield
Medical Pharma - PR Newswire
Mass. Labor Relations Board Issues Final Ruling, Finding Cambridge Hospital Violated State Labor Law By Declaring Impasse & Imposing Its Last Offer Including a 40% Cut to the Nurses' Retiree Health Benefit Without Exhausting Longstanding Requirement

MedQuist to Exhibit at HealthTrust University Conference

Accountable Care Organizations' Impact on Community Oncology - Free Educational Webinar

Inc. Magazine Unveils 29th Annual List of America's Fastest-Growing Private Companiesthe Inc. 500

Electronic Recordkeeping Boosts Patient Safety, Saves DMC More Than $5 Million - For Second Straight Year

 National Center for Biotechnology Information
BLAST NEWS

BLASTFeed

Blast Tips

dbGaP News and Announcements

NCBI News

 Nature Biotechnology
Waking up and smelling the coffee

Reply to Waking up and smelling the coffee

Genetic stability in two commercialized transgenic lines (MON810)

Distances needed to limit cross-fertilization between GM and conventional maize in Europe

Case study: India's billion dollar biotech
New York Times- Biotechnology
Sanofi Makes Public a $18.5 Billion Bid for Genzyme

Sanofi Offers $18.5 Billion for Genzyme

Sanofi Reveals $18.5 Billion Offer for Genzyme

Sanofi Reveals $18.5 Billion Offer to Take Over Genzyme

Sanofi Reveals Its Bid for Genzyme

 New York Times- Pharmaceuticals
Genzyme Rejects $18.5 Billion Offer by Sanofi

Lilly Stops Alzheimer's Drug Trials

AARPSays Brand-Name Drug Prices Up 8% in 2009

AARP Says Brand-Name Drug Prices Up 8% in 2009

What to Tell Alzheimer’s Patients After a Trial Goes Awry

 OnBioVC
Si-Bone, Inc.: Series B $10.6M

Complete Genomics, Inc.: Series E $39M

Poxel, SA: Series A $20.3M

Gemin X Pharmaceuticals, Inc.: Series E $8M

Great Lakes Pharmaceuticals, Inc.: Series B $3.1M
Outsourcing-Pharma
KCAS talks biomarker strategy development

Almac Diagnostics discusses new biomarker service

Asia Pacific trial sector poised for continued growth, says Novotech

ERT develops IVR suicidality monitoring for trials

Demand for discovery services recovering, says Domainex

 Pharma News - Business Wire
BARDA Funds Drug Development for Biothreats, Antibiotic Resistance

Ramsell Public Health Rx Secures Delaware ADAP Contract

Research and Markets: This Onychomycosis Therapy Area Pipeline Report Contains Detailed Information on the Onychomycosis Drug Pipeline

The Apothecary Shops Acquires Greater Sacramento Specialty Pharmacy

Research and Markets: Strategies for Managing Pharmaceutical Workforce and Site Reductions: Analysis of Legal, Productivity, and Quality Control Issues

 Pharma News - PharmiWeb
Epigenetics Therapeutics to 2017 High Market Potential for Epigenetics Drugs in Acute Myeloid Leukemia, Multiple Myeloma and Cutaneous T-Cell Lymphoma

Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Dorothee Foernzler at Roche to speak at Cancer Conference Oct 20-22 California

NICE proposes to restrict access to VelcadeŽ (bortezomib) in newly diagnosed multiple myeloma patients

Key Bio Nano Consulting partner develops novel nanolitre scale technique for determining protein stability and ligand-binding affinity
Pharma News - PR Newswire
InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative

Expert Healthcare Panel Recommends Select Nutritional Support for Baby Boomers for Healthy Aging to Maintain Active Lifestyles

Nigerian Association of Pharmacists and Pharmaceutical Scientists in America (NAPPSA) Announces Prime Vendor Agreement with H. D. Smith

Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference

For Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia, 41 Percent of Surveyed European Hematologist-Oncologists Say MabThera's Favorable Efficacy Profile is the Most Significant Driver of Their Use of This Agent

 Pharmaceutical - Moreover
This Analysis Examines the Historical and Forecast Performance for Johnson & Johnson in the Ethical Pharmaceutical Sector

Macular Degeneration (AMD) And Diabetic Retinopathy Pharmaceutical Market 2010-2025 - New Market Report Published

Research and Markets: This Analysis Examines the Historical and Forecast Performance for GlaxoSmithKline in the

Bank DeGroof cuts Omega Pharma rating to "hold"

SOHM broadens international sales channels in SE Asia

 PR Leap - Biotech
Executive Impact Group Provides Startup Solutions to VC funded $40M Calithera Biosciences

Vivante GMP Solutions Announces Expansion of Technical Staff

Vivante GMP Solutions Announces Successful Completion of GMP Manufacture, Lot Release Campaign

SourceSolution Announces the Implementation of the PlanIt Partner Portal for Vivante GMP Solutions

Vivante GMP Solutions Announces Successful Completion of GMP Fill/Finish, Lot Release Campaign for Etubics Corporation
PRWeb - Biotechnology
Therapure Biopharma Inc.'s Drug Delivery Program for the Treatment of...

Microsonic Systems Enters Asia-Pacific Market

Invida to Participate in Key September Conferences in the U.S.

Johnson & Johnson's DePuy Orthopedics, Inc. Recalls the ASR XL...

Extech Video Borescope Inspection Cameras New from Cole-Parmer

 PRWeb - Pharmaceuticals
NJ Microelectronic Testing Announces Expansion of Engineering Services

Sacramento Law Firm Scrutinizes Johnson & Johnson Again, as the...

Air Innovations Named to Fourth Annual Inc. 5000 List of America's...

Oncology Care Live, Continuing Medical Education Congress Presented by...

Independent Drugstore Lobby to Congress: 'No Transparency For Us, More...

 Scientific American
Stem Cells from Reprogrammed Adult Cells Found to Bring Along Genetic Defects of Their Donors

Calling All Predators: Caterpillar Saliva May Be a Component in Plants' Chemical Alarms

First Ant Genomes Promise Insight into Epigenetics and Longevity

Cancer-Zapping Precision Radiation Beams Could Soon Target Other Diseases

Light Diet: Eating Food without Seeing It May Impede Ability to Judge Hunger
Xconomy Life Sciences
PrimeraDx Names New CEO

$30M Series F for EndoGastric

Genzyme Shoots Down Sanofi-Aventis's Buyout Offer

First Two Startups Leaving CommNexus Incubator, Qualcomm at 25, Oceanhouse Media Shows App-titude for Children's Books, & More San Diego BizTech News

A Bidding War for 3Par, a Trademark War over Mafia Wars, a Barrage of New Y Combinator Startups, & More Bay Area BizTech and Life Sciences News

 Yahoo Biotech News
Genzyme board rejects Sanofi bid (AFP)

Genzyme breaks silence to rebuff Sanofi (Reuters)

Genzyme rejects Sanofi-Aventis' $18.5 billion offer (Reuters)

Sanofi proposal heaps pressure on Genzyme (Reuters)

Sanofi makes $18.5 billion Genzyme offer public (Reuters)


SourceSolution © 2008-2012